Published on 02/12/2025

Top Ongoing Review Gaps—and Fixes

The pharmaceutical industry is governed by stringent regulations to ensure that products are safe and effective. As such, managing ongoing reviews of suppliers, Contractors Manufacturing Organizations (CMOs), and tech providers is pivotal for compliance and operational excellence. In this article, we will systematically explore the ongoing review gaps that practitioners encounter and provide actionable fixes. Structured to serve pharmaceutical professionals in clinical operations, regulatory affairs, and medical affairs in the US, UK, and EU, this guide focuses on key areas such as risk, supplier qualification, quality agreement clauses, CMO oversight, validation deliverables, and vendor audits.

1. Understanding Risk in Supplier Oversight

Risk plays a fundamental role in the pharmaceutical industry, especially concerning supplier oversight. The European Medicines Agency (EMA) emphasizes the necessity of risk assessment to identify the potential impact of third-party suppliers on product quality.

To begin your ongoing review process, follow these steps:

1. Conduct a Risk Assessment: Utilize a systematic approach to assess the risks associated with each supplier. Consider factors such as supplier history, compliance with Good Manufacturing Practices (GMP), and their operational procedures.
2. Develop Risk Scoring Criteria: Base your risk scoring on parameters such as product criticality, supplier performance history, and previous audit findings. Assign scores that reflect the impact of failure on product quality and patient safety.
3. Integrate ICH Q10 Principles: Refer to the International Council for Harmonisation guidelines to develop a quality management system that aligns with your organization’s risk management strategy.

Incorporating a thorough risk assessment ensures that your ongoing review process is systematic and compliant with regulatory expectations.

2. Supplier Qualification and Quality Agreement Clauses

Supplier qualification is essential for maintaining high standards of quality. The consolidation of appropriate FDA guidelines necessitates that quality agreement clauses clearly outline the responsibilities of suppliers regarding quality management.

Follow these steps to refine your supplier qualification process:

1. Define Qualification Criteria: Create a comprehensive set of qualification criteria tailored to your suppliers. Include parameters related to facility inspections, quality metrics, and compliance history.
2. Establish Quality Agreement Clauses: Draft clauses that explicitly state the supplier’s responsibilities regarding quality assurance, deviations, audit rights, and communication protocols. Ensure these clauses are aligned with your internal quality management policies.
3. Review and Update Agreements Regularly: Periodic reviews of quality agreements are critical to adapt to regulatory changes or shifts in your operational needs. Schedule these reviews alongside your ongoing supplier evaluations.

By investing time in supplier qualification and ensuring robust quality agreements, companies can minimize risks associated with outsourced manufacturing.

3. The Role of Validation Deliverables in Ongoing Review

Validation deliverables are critical elements in the pharmaceutical development process and should not be overlooked in ongoing reviews. The importance of validation lies in ensuring that processes and equipment consistently produce products that meet predetermined specifications.

To enhance validation deliverables within your ongoing review framework, take the following steps:

1. Define Validation Expectations: Clearly state the validation requirements applicable to your suppliers, including process validation, cleaning validation, and method transfer equivalence. This should align with guidelines set forth by authoritative bodies like ICH and 21 CFR Part 11.
2. Regularly Review Validation Documents: Establish a schedule for reviewing key validation documents such as validation protocols, reports, and change control records. Ensure that these documents are up-to-date and align with the latest regulatory standards.
3. Utilize Risk-Based Approaches: Implement risk assessments to prioritize validation activities. Focus on critical processes that may impact product quality and ensure that validation is documented and reproducible.

Strengthening the role of validation deliverables in your ongoing reviews aids in sustaining product integrity and regulatory compliance.

4. Conducting Effective Vendor Audits

Vendor audits are an indispensable component of effective supplier management. In line with ISO 9001 and FDA’s quality system regulations, performance assessments of CMOs and suppliers must be routinely conducted to ensure compliance with quality standards.

Consider implementing the following steps in your vendor audit procedures:

1. Develop Comprehensive Audit Checklists: Customize checklists that correspond to the specific processes being audited. This should include areas such as quality management systems, production processes, and laboratory controls.
2. Schedule Regular Audits: Depending on the criticality of the supplier, establish a timeline for conducting vendor audits. High-risk suppliers may require more frequent audits compared to lower-risk providers.
3. Document and Address Audit Findings: Following an audit, document all findings and establish corrective and preventive actions (CAPAs) for any identified deficiencies. Follow-up on CAPAs is crucial to ensure that issues are addressed in a timely manner.

Effectively conducting vendor audits can greatly enhance your overall supplier oversight and adherence to quality requirements.

5. Executing Effective Tech Transfer Packages

Tech transfer from CMOs ensures that technology and manufacturing processes are seamlessly transitioned for production. An inadequate tech transfer may result in deviations that jeopardize product quality.

To improve your tech transfer packages, consider following these recommendations:

1. Ensure Clarity and Completeness: Tech transfer packages should include comprehensive documentation such as detailed SOPs, equipment specifications, and process parameters.
2. Incorporate Method Transfer Equivalence: During the transfer process, ensure that all method validations demonstrate equivalence to maintain consistent product quality. This ensures that any differences in site operations do not adversely affect the product.
3. Facilitate Cross-Functional Collaboration: Foster communication among QA, engineering, and production teams during the tech transfer process. Involvement among various stakeholders helps in identifying and mitigating risks early on.

Successful execution of tech transfer packages ensures seamless transitions and maintains consistency in product quality.

6. Implementing Ongoing Review Processes

Ongoing review is a systematic process that integrates quality oversight through regular assessment of suppliers, CMOs, and tech providers. It allows organizations to proactively identify and mitigate risks while ensuring compliance with regulatory requirements.

To establish an effective ongoing review process, follow these steps:

1. Create a Centralized Review System: Develop a centralized system that houses all ongoing review documentation, including audit results, validation documents, and risk assessments. This fosters transparency and facilitates easier access to essential information.
2. Establish Key Performance Indicators (KPIs): Define KPIs related to supplier performance and quality metrics. Monitor these KPIs regularly to ensure that suppliers meet the agreed-upon standards.
3. Incorporate Feedback Mechanisms: Implement mechanisms for gathering feedback from stakeholders involved in the review process. Continuous feedback helps to refine ongoing review practices and uncovers areas for improvement.

By establishing a robust ongoing review process, organizations can enhance compliance with regulations while improving supplier performance.

Conclusion

Addressing ongoing review gaps is essential for maintaining quality and compliance in the pharmaceutical industry. By effectively managing risks, enhancing supplier qualification and quality agreements, reinforcing validation deliverables, conducting thorough vendor audits, optimizing tech transfer packages, and implementing a solid ongoing review process, organizations can significantly improve their oversight of suppliers, CMOs, and tech providers.

As the landscape of the pharmaceutical industry continues to evolve, staying proactive in supplier oversight will help ensure that quality and compliance expectations are met, ultimately safeguarding public health and enhancing operational efficiency.